Banner year: US FDA approved 39 new drugs/biologics in 2012
This article was originally published in SRA
Executive Summary
While the US Food and Drug Administration did not break any records in 2012 with approvals of new molecular entities (NMEs) and new biologics, the agency was on fire - surpassing by nine the number of nods it gave to novel medicines a year earlier and far outpacing the 21 approved in 2010.